000098586 000__ 01223cas\a2200289W1\4500
000098586 001__ 98586
000098586 005__ 20220217104306.0
000098586 008__ 810403c19uu9999xxuuu\p\\\\\\f0uuu\0eng\d
000098586 035__ $$a(OCoLC)ocm07303524
000098586 035__ $$a00267842
000098586 035__ $$9AAL1242SI
000098586 035__ $$a98586
000098586 040__ $$aOSU$$cOSU$$dISE
000098586 049__ $$aISER
000098586 090__ $$aRS59.U5$$bA3
000098586 099__ $$aRS59.U5 A3
000098586 1101_ $$aUnited States.$$bDrug Enforcement Administration.$$bOffice of Compliance and Regulatory Affairs.$$bInformation Systems Section.
000098586 24510 $$aProject label :$$balphabetical listings by controlled generic drug ingredients.
000098586 260__ $$aWashington, D.C. :$$bDept. of Justice, Drug Enforcement Administration, Office of Compliance and Regulatory Affairs, Regulatory Support Division, Information Systems Section,$$c19  -
000098586 300__ $$av. ;$$c26 cm.
000098586 650_0 $$aDrugs$$xLabeling$$zUnited States.
000098586 85231 $$bdfich$$hJ 24.24/2:
000098586 909CO $$ooai:library.usi.edu:98586$$pGLOBAL_SET
000098586 936__ $$aNov. 1978
000098586 948__ $$anew ed. microfiche$$aceased
000098586 966__ $$c 1$$lUSIREF$$mREF$$sRS59.U5 A3$$dv.2$$xISER$$z090$$b39203009589461
000098586 966__ $$c 1$$lUSIREF$$mREF$$sRS59.U5 A3$$dv.3$$xISER$$z090$$b39203009589479
000098586 966__ $$c 1$$lUSIREF$$mREF$$sRS59.U5 A3$$dv.4$$xISER$$z090$$b39203009589487
000098586 966__ $$c 1$$lUSIREF$$mREF$$sRS59.U5 A3$$dv.1$$xISER$$z090$$b39203009589453
000098586 980__ $$aBIB
000098586 980__ $$aGOV RESOURCE